Skip to main content
Erschienen in: Medical Microbiology and Immunology 5/2016

09.06.2016 | Original Investigation

A versatile qPCR assay to quantify trypanosomatidic infections of host cells and tissues

verfasst von: Eugenia Bifeld, Paloma Tejera Nevado, Janika Bartsch, Julia Eick, Joachim Clos

Erschienen in: Medical Microbiology and Immunology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The majority of PCR-based detection systems for Leishmania spp. and Trypanosoma cruzi aim at high sensitivity and specificity, rather than an accurate parasite load quantification required for experimental infections in basic research and drug development. Here, we describe the use of a dual-labelled probe qPCR to detect and quantify intracellular Old World Leishmania spp. and T. cruzi amastigotes after in vitro and in vivo infection experiments. We show that quantification of parasite actin gene DNA relative to the host cell actin gene DNA accurately reflects the parasite load relative to the host cells and that qPCR quantification is highly sensible to drug-induced cell death. Furthermore, qPCR allows to determine parasite loads even after host cell detachment and/or rupture, important when comparing untreated versus drug-treated samples. The method is also suitable for the quantification of parasites from infected mouse tissue, making it suitable for drug testing and mutant phenotype analysis.
Literatur
1.
Zurück zum Zitat Chagas C (2009) New type of human trypanosomiasis. Bull Soc Pathol Exot 102(5):352–355PubMed Chagas C (2009) New type of human trypanosomiasis. Bull Soc Pathol Exot 102(5):352–355PubMed
2.
Zurück zum Zitat Agrawal S, Rai M, Sundar S (2005) Management of visceral leishmaniasis: Indian perspective. J Postgrad Med 51(Suppl 1):S53–S57PubMed Agrawal S, Rai M, Sundar S (2005) Management of visceral leishmaniasis: Indian perspective. J Postgrad Med 51(Suppl 1):S53–S57PubMed
3.
Zurück zum Zitat Moncayo A, Silveira AC (2009) Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104(Suppl 1):17–30PubMed Moncayo A, Silveira AC (2009) Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104(Suppl 1):17–30PubMed
4.
Zurück zum Zitat Jannin J, Villa L (2007) An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 102(Suppl 1):95–97CrossRefPubMed Jannin J, Villa L (2007) An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 102(Suppl 1):95–97CrossRefPubMed
6.
Zurück zum Zitat Croft SL, Seifert K, Yardley V (2006) Current scenario of drug development for leishmaniasis. Indian J Med Res 123(3):399–410PubMed Croft SL, Seifert K, Yardley V (2006) Current scenario of drug development for leishmaniasis. Indian J Med Res 123(3):399–410PubMed
7.
Zurück zum Zitat Quah BJ, Warren HS, Parish CR (2007) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2(9):2049–2056. doi:10.1038/nprot.2007.296 CrossRefPubMed Quah BJ, Warren HS, Parish CR (2007) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2(9):2049–2056. doi:10.​1038/​nprot.​2007.​296 CrossRefPubMed
9.
Zurück zum Zitat Schulz A, Mellenthin K, Schonian G, Fleischer B, Drosten C (2003) Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41(4):1529–1535CrossRefPubMedPubMedCentral Schulz A, Mellenthin K, Schonian G, Fleischer B, Drosten C (2003) Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41(4):1529–1535CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Mary C, Faraut F, Lascombe L, Dumon H (2004) Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42(11):5249–5255CrossRefPubMedPubMedCentral Mary C, Faraut F, Lascombe L, Dumon H (2004) Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42(11):5249–5255CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Prina E, Roux E, Mattei D, Milon G (2007) Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR. Microbes Infect/Institut Pasteur 9(11):1307–1315CrossRef Prina E, Roux E, Mattei D, Milon G (2007) Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR. Microbes Infect/Institut Pasteur 9(11):1307–1315CrossRef
12.
Zurück zum Zitat Racoosin EL, Swanson JA (1989) Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J Exp Med 170(5):1635–1648CrossRefPubMed Racoosin EL, Swanson JA (1989) Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J Exp Med 170(5):1635–1648CrossRefPubMed
13.
Zurück zum Zitat Racoosin EL, Beverley SM (1997) Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol 85(3):283–295CrossRefPubMed Racoosin EL, Beverley SM (1997) Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol 85(3):283–295CrossRefPubMed
14.
Zurück zum Zitat Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50–60CrossRef Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50–60CrossRef
16.
Zurück zum Zitat Jacobs T, Andra J, Gaworski I, Graefe S, Mellenthin K, Kromer M, Halter R, Borlak J, Clos J (2005) Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection. Med Microbiol Immunol (Berl) 194(3):143–149CrossRef Jacobs T, Andra J, Gaworski I, Graefe S, Mellenthin K, Kromer M, Halter R, Borlak J, Clos J (2005) Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection. Med Microbiol Immunol (Berl) 194(3):143–149CrossRef
19.
Zurück zum Zitat Reiling L, Chrobak M, Schmetz C, Clos J (2010) Overexpression of a singleLeishmania majorgene is sufficient to enhance parasite infectivity in vivo and in vitro. Mol Microbiol 76(5):1175–1190CrossRefPubMedPubMedCentral Reiling L, Chrobak M, Schmetz C, Clos J (2010) Overexpression of a singleLeishmania majorgene is sufficient to enhance parasite infectivity in vivo and in vitro. Mol Microbiol 76(5):1175–1190CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat van der Meide W, Guerra J, Schoone G, Farenhorst M, Coelho L, Faber W, Peekel I, Schallig H (2008) Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites. J Clin Microbiol 46(1):73–78CrossRefPubMed van der Meide W, Guerra J, Schoone G, Farenhorst M, Coelho L, Faber W, Peekel I, Schallig H (2008) Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites. J Clin Microbiol 46(1):73–78CrossRefPubMed
22.
Zurück zum Zitat Nicolas L, Prina E, Lang T, Milon G (2002) Real-time PCR for detection and quantitation of leishmania in mouse tissues. J Clin Microbiol 40(5):1666–1669CrossRefPubMedPubMedCentral Nicolas L, Prina E, Lang T, Milon G (2002) Real-time PCR for detection and quantitation of leishmania in mouse tissues. J Clin Microbiol 40(5):1666–1669CrossRefPubMedPubMedCentral
24.
26.
Zurück zum Zitat Ubeda JM, Legare D, Raymond F, Ouameur AA, Boisvert S, Rigault P, Corbeil J, Tremblay MJ, Olivier M, Papadopoulou B, Ouellette M (2008) Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol 9(7):R115. doi:10.1186/gb-2008-9-7-r115 CrossRefPubMedPubMedCentral Ubeda JM, Legare D, Raymond F, Ouameur AA, Boisvert S, Rigault P, Corbeil J, Tremblay MJ, Olivier M, Papadopoulou B, Ouellette M (2008) Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol 9(7):R115. doi:10.​1186/​gb-2008-9-7-r115 CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Leprohon P, Legare D, Raymond F, Madore E, Hardiman G, Corbeil J, Ouellette M (2009) Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res 37(5):1387–1399. doi:10.1093/nar/gkn1069 CrossRefPubMedPubMedCentral Leprohon P, Legare D, Raymond F, Madore E, Hardiman G, Corbeil J, Ouellette M (2009) Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res 37(5):1387–1399. doi:10.​1093/​nar/​gkn1069 CrossRefPubMedPubMedCentral
28.
Metadaten
Titel
A versatile qPCR assay to quantify trypanosomatidic infections of host cells and tissues
verfasst von
Eugenia Bifeld
Paloma Tejera Nevado
Janika Bartsch
Julia Eick
Joachim Clos
Publikationsdatum
09.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Medical Microbiology and Immunology / Ausgabe 5/2016
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-016-0460-3

Weitere Artikel der Ausgabe 5/2016

Medical Microbiology and Immunology 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.